DIVES MED GMBH SCHONHAUSER
⚠️ High Risk
FEI: 3030400697 • Berlin, Berlin • GERMANY
FEI Number
3030400697
Location
Berlin, Berlin
Country
GERMANYAddress
Allerstr. 10-11, , Berlin, Berlin, Germany
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
NO PMA
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 2/20/2025 | 53LY06MOISTURIZING (SKIN CARE PREPARATIONS) | Division of Southeast Imports (DSEI) | |
| 2/20/2025 | 53LY06MOISTURIZING (SKIN CARE PREPARATIONS) | Division of Southeast Imports (DSEI) | |
| 2/20/2025 | 53LY06MOISTURIZING (SKIN CARE PREPARATIONS) | Division of Southeast Imports (DSEI) | |
| 2/20/2025 | 53LY06MOISTURIZING (SKIN CARE PREPARATIONS) | Division of Southeast Imports (DSEI) | |
| 2/20/2025 | 53LY06MOISTURIZING (SKIN CARE PREPARATIONS) | Division of Southeast Imports (DSEI) | |
| 9/27/2024 | 53YY99OTHER COSMETIC AND COSMETIC PRODUCTS, N.E.C. | Division of Southeast Imports (DSEI) | |
| 9/18/2024 | 66VIY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/7/2024 | 79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE | Division of Northeast Imports (DNEI) | |
| 8/7/2024 | 79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE | Division of Northeast Imports (DNEI) |
Frequently Asked Questions
What is DIVES MED GMBH SCHONHAUSER's FDA import refusal history?
DIVES MED GMBH SCHONHAUSER (FEI: 3030400697) has 9 FDA import refusal record(s) in our database, spanning from 8/7/2024 to 2/20/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. DIVES MED GMBH SCHONHAUSER's FEI number is 3030400697.
What types of violations has DIVES MED GMBH SCHONHAUSER received?
DIVES MED GMBH SCHONHAUSER has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about DIVES MED GMBH SCHONHAUSER come from?
All FDA import refusal data for DIVES MED GMBH SCHONHAUSER is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.